准ACOD1-伊他康酸轴可以稳定动脉样硬化斑块
Karl J Harber1, Annette E Neele2, Cindy Paa van Roomen3
1Department of Medical Biochemistry, Amsterdam UMC, University of Amsterdam, 1105 AZ, Amsterdam, the Netherlands; Amsterdam Cardiovascular Sciences (ACS), Atherosclerosis & Ischemic Syndromes, Amsterdam UMC, the Netherlands; Amsterdam Institute for Infection and Immunity (AII), Inflammatory Diseases, Amsterdam UMC, the Netherlands; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV, Amsterdam, the Netherlands.
阻断甲酸脱糖酶1 (ACOD1) 通过改变巨细胞代谢来稳定动脉样硬化斑块. 这种方法减少了斑块的脆弱性,并为动脉样硬化提供了潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
- 心血管疾病是什么心血管疾病
背景情况:
- 炎症性巨细胞驱动动动脉硬化和斑块破裂.
- 调节巨细胞表型是动脉样硬化的潜在治疗策略.
- 伊塔科纳酸由阿科纳酸脱碳酶1 (ACOD1) 合成,具有免疫调节性质.
研究的目的:
- 为了研究伊塔科纳酸和ACOD1在动脉样硬化中的作用.
- 探索向ACOD1用于动脉样硬化斑块稳定性的潜力.
主要方法:
- 使用Ldlr-/-小鼠移植了Acod1-/-骨髓.
- 采用多组学方法来分析代谢和细胞变化.
- 评估了斑块表型,死核大小,单细胞招募,脂质含量和亡.
主要成果:
- 阿科德1-/- 骨髓移植导致更稳定的斑块与较小的死核.
- 来自Acod1-/-小鼠的巨细胞显示脂质积累增加和亡减少.
- 鉴定了代谢转变,包括改变的纯氨酸代谢和增加甘油醇的生产,以合成甘油三.
结论:
- 在动脉样硬化中,ACOD1在调节巨细胞功能和斑块稳定性方面发挥着重要作用.
- 治疗性地阻断ACOD1可能会稳定动脉样硬化斑块.
- 针对 ACOD1 是治疗动脉样硬化的有希望的策略.
相关概念视频
Inflammation
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Clot Retraction and Fibrinolysis
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...


